BACKGROUND: Developing a noninvasive clinical test to accurately diagnose kidney allograft rejection is critical to improve allograft outcomes. Urinary exosomes, tiny vesicles released into the urine that carry parent cells' proteins and nucleic acids, reflect the biologic function of the parent cells within the kidney, including immune cells. Their stability in urine makes them a potentially powerful tool for liquid biopsy and a noninvasive diagnostic biomarker for kidney-transplant rejection. METHODS: Using 192 of 220 urine samples with matched biopsy samples from 175 patients who underwent a clinically indicated kidney-transplant biopsy, we isolated urinary exosomal mRNAs and developed rejection signatures on the basis of differential gene expression. We used crossvalidation to assess the performance of the signatures on multiple data subsets. RESULTS: An exosomal mRNA signature discriminated between biopsy samples from patients with all-cause rejection and those with no rejection, yielding an area under the curve (AUC) of 0.93 (95% CI, 0.87 to 0.98), which is significantly better than the current standard of care (increase in eGFR AUC of 0.57; 95% CI, 0.49 to 0.65). The exosome-based signature's negative predictive value was 93.3% and its positive predictive value was 86.2%. Using the same approach, we identified an additional gene signature that discriminated patients with T cell-mediated rejection from those with antibody-mediated rejection (with an AUC of 0.87; 95% CI, 0.76 to 0.97). This signature's negative predictive value was 90.6% and its positive predictive value was 77.8%. CONCLUSIONS: Our findings show that mRNA signatures derived from urinary exosomes represent a powerful and noninvasive tool to screen for kidney allograft rejection. This finding has the potential to assist clinicians in therapeutic decision making.
BACKGROUND: Developing a noninvasive clinical test to accurately diagnose kidney allograft rejection is critical to improve allograft outcomes. Urinary exosomes, tiny vesicles released into the urine that carry parent cells' proteins and nucleic acids, reflect the biologic function of the parent cells within the kidney, including immune cells. Their stability in urine makes them a potentially powerful tool for liquid biopsy and a noninvasive diagnostic biomarker for kidney-transplant rejection. METHODS: Using 192 of 220 urine samples with matched biopsy samples from 175 patients who underwent a clinically indicated kidney-transplant biopsy, we isolated urinary exosomal mRNAs and developed rejection signatures on the basis of differential gene expression. We used crossvalidation to assess the performance of the signatures on multiple data subsets. RESULTS: An exosomal mRNA signature discriminated between biopsy samples from patients with all-cause rejection and those with no rejection, yielding an area under the curve (AUC) of 0.93 (95% CI, 0.87 to 0.98), which is significantly better than the current standard of care (increase in eGFR AUC of 0.57; 95% CI, 0.49 to 0.65). The exosome-based signature's negative predictive value was 93.3% and its positive predictive value was 86.2%. Using the same approach, we identified an additional gene signature that discriminated patients with T cell-mediated rejection from those with antibody-mediated rejection (with an AUC of 0.87; 95% CI, 0.76 to 0.97). This signature's negative predictive value was 90.6% and its positive predictive value was 77.8%. CONCLUSIONS: Our findings show that mRNA signatures derived from urinary exosomes represent a powerful and noninvasive tool to screen for kidney allograft rejection. This finding has the potential to assist clinicians in therapeutic decision making.
Authors: Peter R Carroll; J Kellogg Parsons; Gerald Andriole; Robert R Bahnson; Erik P Castle; William J Catalona; Douglas M Dahl; John W Davis; Jonathan I Epstein; Ruth B Etzioni; Thomas Farrington; George P Hemstreet; Mark H Kawachi; Simon Kim; Paul H Lange; Kevin R Loughlin; William Lowrance; Paul Maroni; James Mohler; Todd M Morgan; Kelvin A Moses; Robert B Nadler; Michael Poch; Chuck Scales; Terrence M Shaneyfelt; Marc C Smaldone; Geoffrey Sonn; Preston Sprenkle; Andrew J Vickers; Robert Wake; Dorothy A Shead; Deborah A Freedman-Cass Journal: J Natl Compr Canc Netw Date: 2016-05 Impact factor: 11.908
Authors: K Solez; R A Axelsen; H Benediktsson; J F Burdick; A H Cohen; R B Colvin; B P Croker; D Droz; M S Dunnill; P F Halloran Journal: Kidney Int Date: 1993-08 Impact factor: 10.612
Authors: Kevin C Miranda; Daniel T Bond; Mary McKee; Johan Skog; Teodor G Păunescu; Nicolas Da Silva; Dennis Brown; Leileata M Russo Journal: Kidney Int Date: 2010-04-28 Impact factor: 10.612
Authors: E Akalin; R C Hendrix; R G Polavarapu; T C Pearson; J F Neylan; C P Larsen; F G Lakkis Journal: Transplantation Date: 2001-09-15 Impact factor: 4.939
Authors: Rong Chen; Tara K Sigdel; Li Li; Neeraja Kambham; Joel T Dudley; Szu-Chuan Hsieh; R Bryan Klassen; Amery Chen; Tuyen Caohuu; Alexander A Morgan; Hannah A Valantine; Kiran K Khush; Minnie M Sarwal; Atul J Butte Journal: PLoS Comput Biol Date: 2010-09-23 Impact factor: 4.475
Authors: Nathan R Hill; Samuel T Fatoba; Jason L Oke; Jennifer A Hirst; Christopher A O'Callaghan; Daniel S Lasserson; F D Richard Hobbs Journal: PLoS One Date: 2016-07-06 Impact factor: 3.240
Authors: Sofia Christakoudi; Manohursingh Runglall; Paula Mobillo; Tjir-Li Tsui; Claire Duff; Clara Domingo-Vila; Yogesh Kamra; Florence Delaney; Rosa Montero; Anastasia Spiridou; Theodoros Kassimatis; Sui Phin-Kon; Beatriz Tucker; Christopher Farmer; Terry B Strom; Graham M Lord; Irene Rebollo-Mesa; Daniel Stahl; Steven Sacks; Maria P Hernandez-Fuentes; Paramit Chowdhury Journal: EBioMedicine Date: 2019-03-02 Impact factor: 8.143
Authors: Ronald Tutrone; Michael J Donovan; Phillipp Torkler; Vasisht Tadigotla; Tom McLain; Mikkel Noerholm; Johan Skog; James McKiernan Journal: Prostate Cancer Prostatic Dis Date: 2020-05-07 Impact factor: 5.554
Authors: Charles J Blijdorp; Thomas A Hartjes; Kuang-Yu Wei; Martijn H van Heugten; Dominique M Bovée; Ricardo P J Budde; Jacqueline van de Wetering; Joost G J Hoenderop; Martin E van Royen; Robert Zietse; David Severs; Ewout J Hoorn Journal: J Extracell Vesicles Date: 2022-01